Portal:IEM/CoveredPathways
From WikiPathways
(Updated edition 5 info) |
|||
Line 16: | Line 16: | ||
| 20 || Disorders of phenylalanine and tetrahydrobiopterin metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4156 WP4156] || 1|| style="font-style: italic; color: blue;" | Approved || 7 (+3), non missing | | 20 || Disorders of phenylalanine and tetrahydrobiopterin metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4156 WP4156] || 1|| style="font-style: italic; color: blue;" | Approved || 7 (+3), non missing | ||
|- | |- | ||
- | | 21 || Disorders of tyrosine metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4506 WP4506] || 2|| style="font-style: italic; color: blue;" | Approved || 5, non missing | + | | 21 || Disorders of tyrosine metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4506 WP4506] || 2|| style="font-style: italic; color: blue;" | Approved (ed.5) || 5, non missing |
|- | |- | ||
| 22 || Disorders of sulfur amino acid and sulfide metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4292 WP4292] || 3|| style="font-style: italic; color: blue;" | Approved || 7, non missing | | 22 || Disorders of sulfur amino acid and sulfide metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4292 WP4292] || 3|| style="font-style: italic; color: blue;" | Approved || 7, non missing | ||
Line 66: | Line 66: | ||
| 57 || Disorders of Heme metabolism || [https://www.wikipathways.org/index.php/Pathway:WP5169 WP5169] || 33 || style="font-style: italic; color: blue;" | Approved | | 57 || Disorders of Heme metabolism || [https://www.wikipathways.org/index.php/Pathway:WP5169 WP5169] || 33 || style="font-style: italic; color: blue;" | Approved | ||
|- | |- | ||
- | | 60 || Lysosomal storage disorders || [https://www.wikipathways.org/index.php/Pathway:WP4153 WP4153] || 25|| style="font-style: italic; color: blue;" | Approved | + | | 60 || Lysosomal storage disorders || [https://www.wikipathways.org/index.php/Pathway:WP4153 WP4153] || 25|| style="font-style: italic; color: blue;" | Approved (ed.5) |
|- | |- | ||
| 65 || Disorders of oxalate metabolism || [https://www.wikipathways.org/index.php/Pathway:WP5166 WP5166] || 28 || style="font-style: italic; color: blue;" | Approved | | 65 || Disorders of oxalate metabolism || [https://www.wikipathways.org/index.php/Pathway:WP5166 WP5166] || 28 || style="font-style: italic; color: blue;" | Approved |
Revision as of 09:56, 8 August 2022
Chapter ed. 5 | Title | Links WP | Chapter ed. 4 | Status | Diseases: x from ch. ed. 4 (+y) from other ch. |
---|---|---|---|---|---|
13 | Disorders of pyrimidine and purine metabolism | WP4225 and WP4224 | 41 | Approved | |
15 | Creatine disorders | WP5190 | 32 | Approved | |
16 | Disorders of glutathione metabolism | WP4518 | 42 | Approved | |
17 | Disorders of ammonia detoxification | WP4595 | 4 | Approved | |
18 | Disorders of amino acid transport | WP5029 | 6 | In Progress | |
19 | Disorders of monoamine metabolism | WP4220 | 31 | Approved | |
20 | Disorders of phenylalanine and tetrahydrobiopterin metabolism | WP4156 | 1 | Approved | 7 (+3), non missing |
21 | Disorders of tyrosine metabolism | WP4506 | 2 | Approved (ed.5) | 5, non missing |
22 | Disorders of sulfur amino acid and sulfide metabolism | WP4292 | 3 | Approved | 7, non missing |
23 | Disorders of branched-chain amino acid metabolism | WP4686 | 7 | Approved | |
26 | Disorders of glycine metabolism | Fig.5.1:WP5028, Fig.5.4: WP5026 | 5 | In Progress | |
26 | Disorders of glycine metabolism | Fig.5.2: WP4688 Fig.5.3: WP4157, | 5 | Approved | |
28 | Disorders of cobalamin metabolism | WP4271 | 13 | Approved | |
29 | Disorders of folate metabolism | WP4259 and WP4288 | 10 | Approved | |
30 | Disorders of biotin metabolism | WP5031 | 14 | Approved | |
31 | Disorders of thiamine metabolism | WP4297 | 15 | Approved | |
32 | Disorders of riboflavin metabolism | WP5037 | 16 | Approved | |
34 | Vitamin B6 -Dependent and Responsive Disorders | WP4228 | 11 | Approved | |
35 | Disorders of molybdenum metabolism | WP4507 and WP4504 | 12 | Approved | |
36 | Disorders of copper , zinc and selenium metabolism | WP5189 | 39 | Approved | |
37 | Iron metabolism disorder | WP5172 | 40 | Approved | |
39 | Disorders of carbohydrate and glucose transport | Fig.18.3:WP5173, Fig.18.4: WP5178 | 18 | Approved | |
42 | Disorders of pyruvate and Krebs cycle metabolism | WP4236 | 20 | Approved | |
47 | Primary CoQ10 deficiencies | WP5037 | 16 | Approved | |
48 | Disorders of carnitine, fatty acid and fatty aldehyde metabolism | WP5123 | 17 | In Progress | |
50 | Disorders of ketone body metabolism | Fig.23.1 and 23.2:WP5175, Fig.23.3: WP5195 | 23 | Approved | |
52 | Disorders of eicosanoid metabolism (including leukotrienes) | WP5171 | 38 | Approved | |
53 | Disorders of lipoprotein metabolism | WP4522 | 43 | Approved | |
54 | Cholesterol synthesis disorders | WP5193 | 36 | Approved | |
55 | Disorders of steroid metabolism | WP4523 and WP4524 | 37 | Approved | |
56 | Disorders of Bile acid synthesis (and biliary transport) | WP5176 | 34 | Approved | |
57 | Disorders of Heme metabolism | WP5169 | 33 | Approved | |
60 | Lysosomal storage disorders | WP4153 | 25 | Approved (ed.5) | |
65 | Disorders of oxalate metabolism | WP5166 | 28 | Approved | |
66 | Congenital disorders of N-linked and O-linked glycosylation | WP4521 | 30 | Approved | |
69 | Cerebral organic acidurias | WP4519 and WP5030 | 8 & 9 | Approved | |
- | Disorders of phosphoinositide metabolism | WP4971 | NA | Approved | |
- | Oxysterols derived from cholesterol | WP4545 | NA | Approved | |
- | Mitochondrial oxidative phosphorylation | 22 | In Progress |
Information on Pathway Curation:
This Table provides an overview of which chapters have been covered by WikiPathways. Approved pathways are coloured blue; pathways which still need work (however are a part of the database) are coloured orange.
Tip:
Click on the arrows behind the Table headers to sort this table based on Chapter number (edition 4 and 5 available), title, WikiPathways reference and Curation Status.
Pathway Visualisations
View all digitized Pathways from the Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases by Blau et al. (see it on Scholia.)
How to add a pathway to the portal
The list of Featured Pathways is not static and can be updated at any time. If you know of a pathway that should be added, please contact Denise Slenter.